Cybin updated the market with impressive 12-month efficacy data for its CYB003 Phase 2 trial. Explore more details here.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

James Altucher is an AI expert and one of America's most trusted technology forecasters. Known for his early predictions like for the success of Facebook in 2007 and, Altucher has shown a track record ...

Davos 2025 - giving AI responsibility to CDOs results in great AI no-one uses, says Sanofi CEO Paul Hudson [People] delegate AI to CDOs, and it's the biggest mistake you can make.

Behind the scenes, companies and governments are feeding a trove of data about international travelers into opaque AI tools ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Raritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and ... 2024 Congress as a late-breaking oral presentation showed an ...

Detailed price information for Perspective Therapeutics Inc (CATX-A) from The Globe and Mail including charting and trades.

"The government cannot be a welfare program for everybody doing low quality, low credibility, irreproducible, low value of ...

Recent enforcement operations across Texas have raised concerns among undocumented immigrants. Here’s what immigration attorneys want you to know about your rights and resources.

Protecting skin from photoaging and photocarcinogenesis requires not only sunscreen but also use of topical antioxidants, ...

Shrink Film Beverage Multipacks Market is valued at USD 2.93 billion in 2023 and is projected to reach USD 4.28 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.00% during the ...